SAINT LAURENT, QUEBEC--(Marketwire - April 14, 2008) - IntelGenx Corp. (OTCBB: IGXT) ("IntelGenx" or the "Company") has formed a strategic alliance with DAVA Pharmaceuticals Inc ("DAVA") to develop and commercialize a generic equivalent to a major cardiovascular product using IntelGenx's proprietary Versatab delivery technology.
